Recent Updates
Recently added Catalysts
CAPR Negative Sentiment Score: 30/100

Capricor Therapeutics, Inc. Long-Term Shareholder Announcement: Johnson Fistel Encourages Investors to Reach Out For More Information About Continuing Investigation

Key Takeaway: Johnson Fistel, PLLP is conducting an investigation into potential legal claims on behalf of shareholders of Capricor Therapeutics, Inc. The investigation concerns alleged misconduct by certain officers and directors that may have adversely impacted the company and its investors. Shareholders who have held shares since before October 9, 2024, are encouraged to contact the law firm for more information on their legal rights and possible actions to pursue changes in corporate governance.

Market Sentiment Analysis

CONCERNS & RISKS

  • Investigation into alleged misconduct by Capricor's officers and directors.
  • Potential legal claims may indicate serious issues within the company's governance.
  • Shareholders may be facing uncertainty regarding the company's future performance.

Full Press Release Details

SAN DIEGO, Oct. 03, 2025 (GLOBE NEWSWIRE) -- Johnson Fistel, PLLP is investigating potential legal claims on behalf of Capricor Therapeutics, Inc. (NASDAQ: CAPR) shareholders, concerning alleged misconduct by certain officers and directors that may have harmed the company and its investors.
Investors who have continuously held Capricor shares since before October 9, 2024, may have legal rights and are encouraged to contact the firm to learn more:
You may be able to pursue changes to the company’s corporate governance practices, seek the recovery of funds for the company, and request a court-approved incentive award, all at no cost to you. Please contact Johnson Fistel at (619) 814-4471 to learn more.
About Johnson Fistel, PLLP:
Johnson Fistel is a nationally recognized shareholder rights law firm with offices in California, New York, Georgia, and Colorado. The firm represents individual and institutional investors in derivative and securities class actions and has recovered over $90 million for clients while earning repeated recognition among the Top 10 Plaintiff Law Firms by ISS Securities Class Action Services.
Attorney advertising.
Past results do not guarantee future outcomes.
Services may be performed by attorneys in any of our offices.
Johnson Fistel, PLLP has paid for the dissemination of this promotional communication.
Johnson Fistel, PLLP
501 W. Broadway, Suite 800, San Diego, CA 92101
James Baker, Investor Relations, (619) 814-4471

Tags

Frequently Asked Questions

What is Johnson Fistel investigating?

They are investigating potential legal claims for Capricor Therapeutics shareholders.

When should Capricor shareholders contact Johnson Fistel?

Shareholders who held shares since before October 9, 2024, should reach out.

What can investors potentially recover?

Investors may recover funds and seek changes to corporate governance practices.

How can one contact Johnson Fistel for more information?

Individuals can call them at (619) 814-4471 for more details.

What is Johnson Fistel's reputation in the legal field?

They are recognized as a top plaintiff law firm with significant recoveries for clients.

Last updated: Oct 3, 2025